Enlil Brings AI-Powered MedTech Innovation Into The Fold of NEMIC’s Corporate Membership Program, as 16th Member.
Providence, RI - The New England Medical Innovation Center (NEMIC) is proud to announce that Enlil has joined its growing network as the newest corporate member, bringing cutting-edge, AI-powered infrastructure to the forefront of medical technology innovation into the NEMIC ecosystem.
Enlil is redefining how MedTech companies build, validate, and bring products to market. At the core of its offering is a cloud-native, AI-powered development traceability platform that unifies product development, quality management, and regulatory compliance into a single, intelligent system. By connecting everything from requirements and risk management to documentation and audit readiness, Enlil enables teams to move from concept to clearance faster—without sacrificing compliance or quality.
Purpose-built for the complexities of regulated product development, Enlil leverages a private large language model and its “Ask Lily” AI assistant to automate traditionally manual processes such as document control, training, compliance mapping, and audit preparation. The result is a streamlined, end-to-end workflow that reduces delays, eliminates fragmented systems, and ensures teams are always inspection-ready.
Enlil’s mission—to serve as the backbone powering MedTech innovation—aligns closely with NEMIC’s commitment to accelerating the development and adoption of transformative healthcare solutions. By providing a unified “single source of truth” across the entire product lifecycle, Enlil empowers startups, enterprise teams, and innovation hubs alike to collaborate more effectively, maintain continuous compliance, and scale with confidence.
“Welcoming Enlil into the NEMIC ecosystem reinforces our commitment to building a collaborative, neutral platform where innovation can thrive on the cutting edge of medical innovation” said Andrew Williamson, NEMIC Business + Engagement Manager. “Their purpose-built approach to AI-driven compliance and development represents exactly the kind of future-scaping our network requires, and is designed to support.”
As a NEMIC corporate member, Enlil will play an active role in supporting the broader innovation ecosystem—engaging with early-stage companies, contributing domain expertise, and helping to advance best practices in MedTech development. Their presence strengthens NEMIC’s ability to act as a true convener, bringing together stakeholders across the healthcare continuum to solve complex challenges and accelerate meaningful progress.
“Joining NEMIC is a natural fit for Enlil. The future of MedTech depends on giving innovators the infrastructure to move faster, collaborate better, and stay compliant in an increasingly complex environment” said Nader Fathi, Enlil, CEO. “We’re excited to support NEMIC’s ecosystem and help its network accelerate the path from innovation to patient impact.”
With Enlil joining the corporate membership cohort, NEMIC continues to deepen its capacity to connect innovators with the tools, expertise, and partnerships needed to bring next-generation medical technologies to life.
About Enlil
Enlil is a cloud-native, AI-powered platform designed to unify product development, quality, and regulatory compliance for MedTech innovators within a single, scalable system. Purpose-built for regulated environments, it creates a continuous “digital thread” across the entire product lifecycle—enabling real-time traceability, collaboration, and audit readiness from concept through commercialization. By integrating disciplines such as QMS, product lifecycle management, manufacturing, and regulatory workflows into one intelligent platform, Enlil helps organizations accelerate time to market while maintaining rigorous compliance standards. | enlil.com
